Skip to content

Effect of daily intake of the test food on cholesterol and Arteriosclerosis

Effect of daily intake of the test food on cholesterol and Arteriosclerosis - Effect of daily intake of the test food on cholesterol and Arteriosclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043995
Enrollment
12
Registered
2021-04-21
Start date
2021-05-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LDL choresterol 120-139mg/dL adult men and women

Interventions

test food A containing peptide: 4 Tab/day for 12 week Test food B not containing peptide: 4 Tab/day for 12 week

Sponsors

Tashikani Plus Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) LDL-cholesterol >=120 mg/dl and <139 mg/dl 2) Subjects aged 30 to 70 years old 3) Gender: No preference 4) Subjects without smoking habits 5) Subjects who do not have a habit of taking a meal containing a large amount of the test foods 6) Subjects who do not regularly use health foods 7) Subjects who do not suffer from lifestyle diseases (high blood pressure, diabetes etc.), rheumatism, liver disorders, renal disorders, other chronic diseases 8) Subjects who have no history of treatment of malignant tumor, heart failure, myocardial infarction 9) Subjects who have no history of allergy to test foods/medicines 10) Subjects who do not take medication for Outpatient treatment 11) Subjects giving written informed consent

Exclusion criteria

Exclusion criteria: 1) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period 2) Subjects who are participating the other clinical tests. Subjects who participated within 3-month prior to the current study 3) Subjects who do not comply with instructions from the doctor or medical staff 4) Others who have been determined ineligible by investigator

Design outcomes

Primary

MeasureTime frame
LDL cholesterol

Secondary

MeasureTime frame
Total cholesterol, HDL cholesterol, non-HDL cholesterol, triglyceride (TG), remnant-like Particle cholesterol (RLP-C), apolipoprotein B, lipoprotein fractionation (VLDL, small -dense LDL, LDL, HDL), LOX-index,8-OHdG

Countries

Japan

Contacts

Public ContactTaisuke Fukaya

Tashikani Plus Co., Ltd CEO

fukaya@tashikani.jp06-6352-6622

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026